Cargando…

Cross-Adversarial Learning for Molecular Generation in Drug Design

Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Banghua, Li, Linjie, Cui, Yue, Zheng, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815768/
https://www.ncbi.nlm.nih.gov/pubmed/35126153
http://dx.doi.org/10.3389/fphar.2021.827606
_version_ 1784645304884133888
author Wu, Banghua
Li, Linjie
Cui, Yue
Zheng, Kai
author_facet Wu, Banghua
Li, Linjie
Cui, Yue
Zheng, Kai
author_sort Wu, Banghua
collection PubMed
description Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with the problems of generation validity and semantic information of labels. Considering these challenges, we propose a cross-adversarial learning method for molecular generation, CRAG for short, which integrates both the facticity of VAE-based methods and the diversity of GAN-based methods to further exploit the complex properties of Molecules. To be specific, an adversarially regularized encoder-decoder is used to transform molecules from simplified molecular input linear entry specification (SMILES) into discrete variables. Then, the discrete variables are trained to predict property and generate adversarial samples through projected gradient descent with corresponding labels. Our CRAG is trained using an adversarial pattern. Extensive experiments on two widely used benchmarks have demonstrated the effectiveness of our proposed method on a wide spectrum of metrics. We also utilize a novel metric named Novel/Sample to measure the overall generation effectiveness of models. Therefore, CRAG is promising for AI-based molecular design in various chemical applications.
format Online
Article
Text
id pubmed-8815768
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88157682022-02-05 Cross-Adversarial Learning for Molecular Generation in Drug Design Wu, Banghua Li, Linjie Cui, Yue Zheng, Kai Front Pharmacol Pharmacology Molecular generation is an important but challenging task in drug design, as it requires optimization of chemical compound structures as well as many complex properties. Most of the existing methods use deep learning models to generate molecular representations. However, these methods are faced with the problems of generation validity and semantic information of labels. Considering these challenges, we propose a cross-adversarial learning method for molecular generation, CRAG for short, which integrates both the facticity of VAE-based methods and the diversity of GAN-based methods to further exploit the complex properties of Molecules. To be specific, an adversarially regularized encoder-decoder is used to transform molecules from simplified molecular input linear entry specification (SMILES) into discrete variables. Then, the discrete variables are trained to predict property and generate adversarial samples through projected gradient descent with corresponding labels. Our CRAG is trained using an adversarial pattern. Extensive experiments on two widely used benchmarks have demonstrated the effectiveness of our proposed method on a wide spectrum of metrics. We also utilize a novel metric named Novel/Sample to measure the overall generation effectiveness of models. Therefore, CRAG is promising for AI-based molecular design in various chemical applications. Frontiers Media S.A. 2022-01-21 /pmc/articles/PMC8815768/ /pubmed/35126153 http://dx.doi.org/10.3389/fphar.2021.827606 Text en Copyright © 2022 Wu, Li, Cui and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wu, Banghua
Li, Linjie
Cui, Yue
Zheng, Kai
Cross-Adversarial Learning for Molecular Generation in Drug Design
title Cross-Adversarial Learning for Molecular Generation in Drug Design
title_full Cross-Adversarial Learning for Molecular Generation in Drug Design
title_fullStr Cross-Adversarial Learning for Molecular Generation in Drug Design
title_full_unstemmed Cross-Adversarial Learning for Molecular Generation in Drug Design
title_short Cross-Adversarial Learning for Molecular Generation in Drug Design
title_sort cross-adversarial learning for molecular generation in drug design
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815768/
https://www.ncbi.nlm.nih.gov/pubmed/35126153
http://dx.doi.org/10.3389/fphar.2021.827606
work_keys_str_mv AT wubanghua crossadversariallearningformoleculargenerationindrugdesign
AT lilinjie crossadversariallearningformoleculargenerationindrugdesign
AT cuiyue crossadversariallearningformoleculargenerationindrugdesign
AT zhengkai crossadversariallearningformoleculargenerationindrugdesign